Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine : Utiliser l'apprentissage machine pour pr édire la rémission chez les patients souffrant de trouble dépressif majeur traités par desvenlafaxine

CONCLUSIONS: Our model, based on 26 clinical features, proved sufficient to predict DVS remission significantly better than chance. This may allow more accurate use of DVS without waiting 8 weeks to determine treatment outcome, and may serve as a first step toward changing psychiatric care by incorporating clinical assistive technologies using machine-learned models.PMID:34379019 | DOI:10.1177/07067437211037141

Source: Canadian Journal of Psychiatry - August 11, 2021 Category: Psychiatry Authors: James R A Benoit Serdar M Dursun Russell Greiner Bo Cao Matthew R G Brown Raymond W Lam Andrew J Greenshaw Source Type: research